CELLULARLINE SPA (CELL.MI) Stock Fundamental Analysis
Europe • Euronext Milan • BIT:CELL • IT0005244618
2.59 EUR
-0.03 (-1.15%)
Last: Feb 9, 2026, 07:00 PM
CELL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 34 industry peers in the Technology Hardware, Storage & Peripherals industry. While CELL has a great health rating, there are worries on its profitability. CELL is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- CELL had positive earnings in the past year.
- In the past year CELL had a positive cash flow from operations.
- In multiple years CELL reported negative net income over the last 5 years.
- In the past 5 years CELL always reported a positive cash flow from operatings.
1.2 Ratios
- CELL has a Return On Assets of 2.60%. This is comparable to the rest of the industry: CELL outperforms 50.00% of its industry peers.
- With a Return On Equity value of 4.27%, CELL perfoms like the industry average, outperforming 55.88% of the companies in the same industry.
- CELL has a Return On Invested Capital (4.42%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.6% | ||
| ROE | 4.27% | ||
| ROIC | 4.42% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- CELL's Profit Margin of 3.44% is in line compared to the rest of the industry. CELL outperforms 50.00% of its industry peers.
- In the last couple of years the Profit Margin of CELL has declined.
- The Operating Margin of CELL (4.91%) is comparable to the rest of the industry.
- CELL's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 40.07%, CELL is in line with its industry, outperforming 58.82% of the companies in the same industry.
- In the last couple of years the Gross Margin of CELL has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.91% | ||
| PM (TTM) | 3.44% | ||
| GM | 40.07% |
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
2. Health
2.1 Basic Checks
- CELL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- CELL has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, CELL has less shares outstanding
- CELL has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.35 indicates that CELL is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a decent Altman-Z score value of 2.35, CELL is doing good in the industry, outperforming 61.76% of the companies in the same industry.
- CELL has a debt to FCF ratio of 2.46. This is a good value and a sign of high solvency as CELL would need 2.46 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 2.46, CELL is in the better half of the industry, outperforming 73.53% of the companies in the same industry.
- A Debt/Equity ratio of 0.13 indicates that CELL is not too dependend on debt financing.
- CELL has a better Debt to Equity ratio (0.13) than 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 2.46 | ||
| Altman-Z | 2.35 |
ROIC/WACC0.47
WACC9.36%
2.3 Liquidity
- CELL has a Current Ratio of 2.12. This indicates that CELL is financially healthy and has no problem in meeting its short term obligations.
- CELL's Current ratio of 2.12 is fine compared to the rest of the industry. CELL outperforms 79.41% of its industry peers.
- CELL has a Quick Ratio of 1.33. This is a normal value and indicates that CELL is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.33, CELL is in the better half of the industry, outperforming 73.53% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.33 |
3. Growth
3.1 Past
- CELL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.78%, which is quite impressive.
- The earnings per share for CELL have been decreasing by -20.43% on average. This is quite bad
- CELL shows a small growth in Revenue. In the last year, the Revenue has grown by 3.54%.
- Measured over the past years, CELL shows a small growth in Revenue. The Revenue has been growing by 3.18% on average per year.
EPS 1Y (TTM)60.78%
EPS 3YN/A
EPS 5Y-20.43%
EPS Q2Q%-4.76%
Revenue 1Y (TTM)3.54%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%-2.91%
3.2 Future
- Based on estimates for the next years, CELL will show a small growth in Earnings Per Share. The EPS will grow by 2.47% on average per year.
- The Revenue is expected to decrease by -0.60% on average over the next years.
EPS Next Y-15%
EPS Next 2Y2.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.17%
Revenue Next 2Y-0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 9.96 indicates a reasonable valuation of CELL.
- Based on the Price/Earnings ratio, CELL is valued cheaply inside the industry as 88.24% of the companies are valued more expensively.
- The average S&P500 Price/Earnings ratio is at 28.23. CELL is valued rather cheaply when compared to this.
- With a Price/Forward Earnings ratio of 6.05, the valuation of CELL can be described as very cheap.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of CELL indicates a rather cheap valuation: CELL is cheaper than 97.06% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 28.01. CELL is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.96 | ||
| Fwd PE | 6.05 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CELL is valued cheaper than 94.12% of the companies in the same industry.
- 100.00% of the companies in the same industry are more expensive than CELL, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.8 | ||
| EV/EBITDA | 3.01 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.47%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- CELL has a Yearly Dividend Yield of 3.55%.
- CELL's Dividend Yield is rather good when compared to the industry average which is at 0.96. CELL pays more dividend than 91.18% of the companies in the same industry.
- CELL's Dividend Yield is rather good when compared to the S&P500 average which is at 1.79.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.55% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- CELL pays out 34.37% of its income as dividend. This is a sustainable payout ratio.
DP34.37%
EPS Next 2Y2.47%
EPS Next 3YN/A
BIT:CELL (2/9/2026, 7:00:00 PM)
2.59
-0.03 (-1.15%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)11-05 2025-11-05
Earnings (Next)03-09 2026-03-09
Inst Owners4.94%
Inst Owner ChangeN/A
Ins Owners19.57%
Ins Owner ChangeN/A
Market Cap56.64M
Revenue(TTM)164.26M
Net Income(TTM)5.65M
Analysts82.86
Price Target4.18 (61.39%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.55% |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP34.37%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.96 | ||
| Fwd PE | 6.05 | ||
| P/S | 0.34 | ||
| P/FCF | 3.8 | ||
| P/OCF | 2.79 | ||
| P/B | 0.43 | ||
| P/tB | 1.04 | ||
| EV/EBITDA | 3.01 |
EPS(TTM)0.26
EY10.04%
EPS(NY)0.43
Fwd EY16.54%
FCF(TTM)0.68
FCFY26.34%
OCF(TTM)0.93
OCFY35.84%
SpS7.51
BVpS6.05
TBVpS2.49
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.6% | ||
| ROE | 4.27% | ||
| ROCE | 5.04% | ||
| ROIC | 4.42% | ||
| ROICexc | 5.33% | ||
| ROICexgc | 12.93% | ||
| OM | 4.91% | ||
| PM (TTM) | 3.44% | ||
| GM | 40.07% | ||
| FCFM | 9.08% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y46.34%
ROICexgc growth 5Y-17.53%
ROICexc growth 3Y77.77%
ROICexc growth 5Y-8.95%
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
F-Score4
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 2.46 | ||
| Debt/EBITDA | 0.81 | ||
| Cap/Depr | 39.19% | ||
| Cap/Sales | 3.28% | ||
| Interest Coverage | 2.77 | ||
| Cash Conversion | 93.13% | ||
| Profit Quality | 264.18% | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.33 | ||
| Altman-Z | 2.35 |
F-Score4
WACC9.36%
ROIC/WACC0.47
Cap/Depr(3y)26.8%
Cap/Depr(5y)35.01%
Cap/Sales(3y)3.22%
Cap/Sales(5y)4.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.78%
EPS 3YN/A
EPS 5Y-20.43%
EPS Q2Q%-4.76%
EPS Next Y-15%
EPS Next 2Y2.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.54%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%-2.91%
Revenue Next Year-6.17%
Revenue Next 2Y-0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.25%
EBIT growth 3Y54.08%
EBIT growth 5Y-17%
EBIT Next Year25.99%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1050.19%
FCF growth 3Y4.84%
FCF growth 5Y6.28%
OCF growth 1Y730.91%
OCF growth 3Y4.12%
OCF growth 5Y1.2%
CELLULARLINE SPA / CELL.MI FAQ
What is the ChartMill fundamental rating of CELLULARLINE SPA (CELL.MI) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CELL.MI.
What is the valuation status for CELL stock?
ChartMill assigns a valuation rating of 7 / 10 to CELLULARLINE SPA (CELL.MI). This can be considered as Undervalued.
What is the profitability of CELL stock?
CELLULARLINE SPA (CELL.MI) has a profitability rating of 3 / 10.
What are the PE and PB ratios of CELLULARLINE SPA (CELL.MI) stock?
The Price/Earnings (PE) ratio for CELLULARLINE SPA (CELL.MI) is 9.96 and the Price/Book (PB) ratio is 0.43.
Can you provide the dividend sustainability for CELL stock?
The dividend rating of CELLULARLINE SPA (CELL.MI) is 6 / 10 and the dividend payout ratio is 34.37%.